Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to audit the effects of changing all hemodialysis patients from
intravenous to subcutaneous administration of ESA's, to ensure that a cost-saving is achieved
and that this does not occur at the expense of anemia control. The dose changes will occur
according to usual clinical care of patients and not along a protocol.